Sphygmomanometer Market Size, Share, and Trends 2024 to 2033

Sphygmomanometer Market (By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer; By Operation: Electric, Manual, Automatic, Semi-automatic; By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted; By End User: Hospitals, Ambulatory Surgical Centers & Clinics, Home Healthcare, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : June 2024
  • Report Code : 2233
  • Category : Healthcare

Sphygmomanometer Market Size and Companies

The global sphygmomanometer market size was USD 2.62 billion in 2023, accounted for USD 2.85 billion in 2024, and is expected to reach around USD 6.19 billion by 2033, expanding at a CAGR of 9% from 2024 to 2033.

Sphygmomanometer Market Size 2024 to 2033

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Sphygmomanometer Market Key Takeaways

  • North America region has captured a major revenue share of 34.34% in 2023.
  • By product, the electronic sphygmomanometer segment held the highest share of over 37.6% in 2023.
  • By operations, the manual segment held the highest market share of over 33.6% in 2023.
  • By configuration, the portable segment accounted for 29.8% in the year 2023.
  • By end-user, the hospitals segment has contributed 31.9% of the market share in 2023.

U.S. Sphygmomanometer Market Size and Growth 2024 to 2033

The U.S. sphygmomanometer market size was estimated at USD 630 billion in 2023 and is predicted to be worth around USD 1,580 billion by 2033, at a CAGR of 9.6% from 2024 to 2033.

U.S. Sphygmomanometer Market Size 2024 to 2033

Because of its highly regulated and established healthcare system, North America held the greatest revenue share of more than 34.34% in 2023. Increasing investments in the development of accurate and effective BP monitors is projected to contribute to the growth of the blood pressure monitoring device business in the future years. Furthermore, new product releases and technology improvements are projected to fuel market expansion. For example, Hillrom announced the commercial debut of the Welch Allyn Spot Vital Signs 4400 in February 2020, which is an easy-to-use next-generation vital signs equipment designed to enhance hypertension identification in ambulatory and emergency department settings.

Asia-Pacific, on the other hand, is predicted to rise rapidly throughout the forecast period due to the availability of unexplored potential, rising hypertension prevalence and rising awareness levels. Rapidly improved healthcare facilities, as well as an increase in the number of misdiagnosed driving regional market expansion. Government attempts to raise public awareness, as well as a fast rising target disease population base, are all contributing to the lucrative growth of the BP monitoring devices market in this area.

For example, in May 2018, the Indian Council of Medical Research (ICMR) launched the "May Measurement Month 2018" campaign in partnership with the Public Health Foundation of India to raise awareness about blood pressure, which is the main cause of mortality and morbidity in India.

Sphygmomanometer Market Share, By Region, 2023 (%)

Market Overview

A sphygmomanometer is a device used to measure blood pressure by detecting the force of the blood in the heart. For individuals with heart problems, it is critical to monitor blood pressure with a sphygmomanometer. A single device may measure many metrics, including pulse rate and heartbeat rate, in addition to blood pressure. Sphygmomanometers are cheap, long-lasting, lightweight, and portable. The rising prevalence of chronic disorders such as hypertension and ischemic heart disease is propelling the industry forward.

The sphygmomanometer is made up of a rubber cup wrapped around the arm, a bulb to inate the cup, a valve to release the pressure, and a measuring device to measure the pressure of the cup. An oscillometric measuring method is used by a digital or electronic sphygmomanometer. It is simple to use, battery-powered, automated, and devoid of mercury. Manual, automated, wrist, upper arm, neonatal, and paediatrics sphygmomanometers are examples of digital sphygmomanometers. Wrist and automated digital sphygmomanometers are the most regularly utilised.

The rise in the incidence of chronic illnesses such as diabetes, hypertension, and ischemic heart disease is one of the primary reasons driving market expansion. According to the World Health Organization (WHO), an estimated 1.13 billion people worldwide had hypertension in 2019, and cardiovascular disease (CVDs) is the leading cause of mortality worldwide, claiming an estimated 17.9 million lives per year.

Long-term blood pressure management and monitoring is required for individuals at risk of cardiovascular problems; this factor is expected to drive market growth throughout the forecast period. Furthermore, technological improvements in the manufacture of mobile and wireless sphygmomanometers are expected to propel market expansion during the forecast period. The overall market development may be ascribed to expanding healthcare awareness, an ageing population, and technological improvements.

Furthermore, increased activities by governmental and private organisations to enhance healthcare throughout the world are fueling the market's rise.

Sphygmomanometer Market Growth Factors

The global sphygmomanometer market is predicted to develop significantly as a result of the evolution of improved sphygmomanometers, rising innovations in sphygmomanometer devices, and increased usage of sphygmomanometer for self-monitoring to limit the risk of infection. The market will be hampered by a decline in the use of mercury thermometers and an increase in the use of blood pressure monitors by healthcare providers that carry numerous diseases and germs. The development of a cloud-based healthcare system is a component generating market growth opportunities.

Sphygmomanometer Market Scope

Report Coverage Details
Market Size in 2023 USD 3.14 Billion
Market Size in 2024 USD 3.14 Billion
Market Size by 2033 USD 3.14 Billion
Growth Rate from 2024 to 2033 CAGR of 9%
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered Product, Operation, Configuration, and End User
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Sphygmomanometer Market

Key Market Drivers

Increasing incidences of hypertension

  • Increasing prevalence of hypertension as a result of changing lifestyles is the primary factor driving industry expansion during the anticipated period. According to a World Health Organization (WHO) report published in 2019, around 1.28 billion individuals worldwide suffered from hypertension, which is a major cause of early mortality. The demand for blood pressure monitors is quite strong due to the expanding senior population base and the increased risk of lifestyle-related illnesses across a broad population base due to rising obesity and sedentary lifestyle rates.
  • Blood pressure should be monitored twice daily for seven consecutive days, preferably in the morning and evening, with two measurements taken 1-2 minutes apart on each occasion, according to the American Heart Association and the American Society of Hypertension, as well as the European Society of Hypertension and the National Institute for Health and Care Excellence (NICE), fueling demand for BP monitors. 

Advancements such as mobile-based bp monitoring systems

  • Advances such as mobile-based blood pressure monitoring devices and digital sphygmomanometers are expected to stimulate demand. Wearable and portable blood pressure measurement devices, as well as mobile phones, are gaining popularity due to related benefits such as wireless transfer of patient information and ease of use. New technologies, such as mHealth, which assists patients with treatment and medication adherence in chronic illness management, are expected to boost market expansion. It aids in the tracking of the patient's health information, prescription regimen, and therapy follow-up. These connected benefits are some of the variables that are projected to drive corporate growth.
  • The growing global incidence of hypertension has resulted in an increase in the demand for home monitoring devices over time. Furthermore, connected benefits with automated equipment such as repeated blood pressure measures to ensure accuracy and a prohibition on mercury devices are factors driving the worldwide blood pressure monitoring devices market expansion. Self-measurement devices are expected to expand in popularity throughout the projection period due to related benefits such as improved monitoring, detection, and control. For the monitoring of blood pressure, automated blood pressure monitors are available in a variety of configurations, including the arm, wrist, and fingers.

Key Market Challenges 

  • Lack of skilled professionals-: Over the projection period, the aneroid sphygmomanometer market may be hampered by a shortage of skilled staff that is unable to operate this equipment.
  • Also, despite the increased frequency of the disorders, the expensive cost of these devices may impede the growth of the worldwide aneroid sphygmomanometer market.

Key Market Opportunities

  • Increase in healthcare professionals: Sphygmomanometers are now used by practically all doctors and nurses to treat patients. According to a recent Athena Health report, the overall number of doctors in the United States has expanded by around 150% over the previous several decades. With a rise in the number of doctors, there is a greater need for and adoption of basic diagnostic equipment, such as blood pressure monitors.

Product Insights

Due to its increasing demand in 2023, the aneroid BP monitors/sphygmomanometers segment has held the highest market share at more than 42.0%. Technological developments, together with new product introductions, are projected to increase global demand for sphygmomanometers. Demand for digital sphygmomanometers is predicted to grow at a rapid pace due to benefits such as accuracy and convenience of use.

Furthermore, continual technical advancements in the consumer healthcare segment, such as innovations in wearable technology, applications, and mobiles, the falling average selling price for retailers and manufacturers, and increased penetration in the professional market, are driving company expansion. Microlife WatchBP home A, QardioArm, LifeSource Sophisticated one-step auto inflate blood pressure monitor, and Omron healthcare's iHealth blood pressure monitor are examples of technologically advanced digital BP monitors on the market.

Blood pressure cuffs are predicted to expand at a substantial rate throughout the forecast period, owing to increased use of blood pressure monitors and the rising prevalence of high blood pressure. These cuffs are available in a variety of sizes depending on the patient. There are two sorts of cuffs on the market: disposable and reusable. The disposable category, in particular, is expected to rise at a rapid CAGR due to rising use of eco-friendly goods and growing worry over hospital-based cross-contamination occurrences.

End-user Insights

The end-use categories examined in the blood pressure monitoring devices market include hospitals and clinics, ambulatory surgery centres, and home healthcare. Due to the availability of a broad patient pool, hospitals and clinics accounted for the biggest revenue share as of 2023. The desire for cost-effective, quick, and accurate diagnostic tools for better health outcomes is driving the use of blood pressure monitoring devices.

Over the projection period, home healthcare is expected to grow at a healthy CAGR of roughly 12.6%. The cost-effectiveness of this alternative option for BP monitoring, along with the availability of smart wearables that allow mobility, is projected to fuel expansion. As a result, the trend toward independent living is likely to push the home healthcare industry. Ambulatory blood pressure monitoring (ABMP) is a method of measuring out-of-office blood pressure measurements at defined time intervals during a 24-hour period. ABPM provides a more accurate technique of predicting long-term cardiovascular disease outcomes.

Sphygmomanometer Market Companies

  • A & D Company (India)
  • Welch Allyn (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • General Electric (U.S.)
  • Omron (Japan)
  • Beurer GmbH (Germany)
  • Paul Hartmann AG (Germany)
  • Microlife Corporation (Switzerland)
  • American Diagnostic (U.S.)
  • Rossmax International (Japan)
  • Rudolf Riester GmbH (Germany)
  • Briggs Healthcare (U.S.)
  • Terumo Corporation (Japan)

Recent Developments

  • February 2019: PhysIQ Inc. and Omron Healthcare have agreed into a cooperation agreement to integrate Omron's HeartGuide wearable blood pressure monitor into the pinpointIQ platform, which is utilised in outpatient clinics. Such efforts are projected to create profitable potential in this industry.
  • January 2020: Spengler and Holtex merged to become a major medical equipment firm. The acquisition is projected to improve the company's sales and distribution network as well as its commercial earnings.

Market Segmentation

By Product

  • Electronic Sphygmomanometer
  • Aneroid Sphygmomanometer
  • Mercury Sphygmomanometer

By Operation

  • Electric
  • Manual
  • Automatic
  • Semi-automatic

By Configuration

  • Portable
  • Desk Mounted
  • Floor Standing
  • Wall Mounted 

By End-User

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global sphygmomanometer market size was accounted at USD 2.62 billion in 2023 and it is expected to reach around USD 6.19 billion by 2033.

The global sphygmomanometer market is poised to grow at a CAGR of 9% from 2024 to 2033.

The major players operating in the sphygmomanometer market are A & D Company (India), Welch Allyn (U.S.), Koninklijke Philips N.V. (Netherlands), General Electric (U.S.), Omron (Japan), Beurer GmbH (Germany), Paul Hartmann AG (Germany), Microlife Corporation (Switzerland), American Diagnostic (U.S.), Rossmax International (Japan), Rudolf Riester GmbH (Germany), Briggs Healthcare (U.S.), Terumo Corporation (Japan)

Increasing incidences of hypertension and advancements such as mobile-based bp monitoring systems these are driving the growth of the sphygmomanometer market.

North America region will lead the global sphygmomanometer market during the forecast period 2024 to 2033.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client